Hormonal status in protracted critical illness and in-hospital mortality

Critical Care

Volumn 15, Issue 1, 2011, Pages

  Sharshar, Tarek ^a   Bastuji Garin, Sylvie ^b   Polito, Andrea ^a   De Jonghe, Bernard ^c   Stevens, Robert D ^d   Maxime, Virginie ^a   Rodriguez, Pablo ^b   Cerf, Charles ^b   Outin, Hervé ^c   Touraine, Philippe ^e   Laborde, Kathleen ^f  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c Poissy Saint Germain en Laye University Hospital   (France)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; ESTRADIOL; FOLLITROPIN; GLUCOSE; HYDROCORTISONE; HYPERTENSIVE FACTOR; LUTEINIZING HORMONE; PRASTERONE; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN; BIOLOGICAL MARKER;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; CONSCIOUSNESS; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HORMONE METABOLISM; HOSPITAL ADMISSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTENSIVE CARE UNIT; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; WAKEFULNESS; BLOOD; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; SEX DIFFERENCE; STATISTICS; SURVIVAL;

AGED; BIOLOGICAL MARKERS; CRITICAL ILLNESS; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HOSPITAL MORTALITY; HUMANS; HYDROCORTISONE; INSULIN-LIKE GROWTH FACTOR I; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 79551511511     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10010     Document Type: Article

References (38)

1. Arlt W, Hammer F, Sanning P, Butcher SK, Lord JM, Allolio B, Annane D, Stewart PM. Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock. J Clin Endocrinol Metab 2006, 91:2548-2554. 10.1210/jc.2005-2258, 16608898.
2. Marx C, Petros S, Bornstein SR, Weise M, Wendt M, Menschikowski M, Engelmann L, Hoffken G. Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: diverse time course of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol. Crit Care Med 2003, 31:1382-1388. 10.1097/01.CCM.0000063282.83188.3D, 12771606.
3. May AK, Dossett LA, Norris PR, Hansen EN, Dorsett RC, Popovsky KA, Sawyer RG. Estradiol is associated with mortality in critically ill trauma and surgical patients. Crit Care Med 2008, 36:62-68. 10.1097/01.CCM.0000292015.16171.6D, 2654262, 18090358.
4. Ray DC, Macduff A, Drummond GB, Wilkinson E, Adams B, Beckett GJ. Endocrine measurements in survivors and non-survivors from critical illness. Intensive Care Med 2002, 28:1301-1308. 10.1007/s00134-002-1427-y, 12209281.
5. Vanhorebeek I, Langouche L, Van den Berghe G. Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2006, 2:20-31. 10.1038/ncpendmet0071, 16932250.
6. Timmins AC, Cotterill AM, Hughes SC, Holly JM, Ross RJ, Blum W, Hinds CJ. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. Crit Care Med 1996, 24:1460-1466. 10.1097/00003246-199609000-00006, 8797616.
7. Marx C, Höffken G, Petros S. Adrenocortical function and inflammatory response during sepsis. Crit Care Med 2002, 30:1937-1938. 10.1097/00003246-200208000-00064, 12163837.
8. De Jonghe B, Finfer S. Critical illness neuromyopathy: from risk factors to prevention. Am J Respir Crit Care Med 2007, 175:424-425. 10.1164/rccm.200612-1762ED, 17303895.
9. Annane D, Sebille V, Troche G, Raphael JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000, 283:1038-1045. 10.1001/jama.283.8.1038, 10697064.
10. Langouche L, Van den Berghe G. The dynamic neuroendocrine response to critical illness. Endocrinol Metab Clin North Am 2006, 35:777-791. ix, 10.1016/j.ecl.2006.09.007, 17127146.
11. Sharshar T, Bastuji-Garin S, De Jonghe B, Stevens RD, Polito A, Maxime V, Rodriguez P, Cerf C, Outin H, Touraine P, Laborde K. Hormonal status and ICU-acquired paresis in critically ill patients. Intensive Care Med 2010, 36:1318-1326. 10.1007/s00134-010-1840-6, 20333354.
12. Sharshar T, Bastuji-Garin S, Stevens RD, Durand MC, Malissin I, Rodriguez P, Cerf C, Outin H, De Jonghe B. Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med 2009, 37:3047-3053. 10.1097/CCM.0b013e3181b027e9, 19770751.
13. De Jonghe B, Bastuji-Garin S, Durand MC, Malissin I, Rodrigues P, Cerf C, Outin H, Sharshar T. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med 2007, 35:2007-2015. 10.1097/01.ccm.0000281450.01881.d8, 17855814.
14. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphaël JC, Outin H, Bastuji-Garin S. Paralysis acquired in the intensive care unit: a prospective multicenter cohort study. JAMA 2002, 288:862-871. 10.1001/jama.288.22.2859, 12186604.
15. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.270.24.2957, 8254858.
16. Fagon JY, Chastre J, Novara A, Medioni P, Gibert C. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med 1993, 19:137-144. 10.1007/BF01720528, 8315120.
17. Bondanelli M, Zatelli MC, Ambrosio MR, degli Uberti EC. Systemic illness. Pituitary 2008, 11:187-207. 10.1007/s11102-008-0112-8, 18404385.
18. Sharshar T, Bastuji-Garin S, Stevens RD, Durand MC, Malissin I, Rodriguez P, Cerf C, Outin H, De Jonghe B. Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med 2009, 37:3047-3053. 10.1097/CCM.0b013e3181b027e9, 19770751.
19. Gebhart SS, Watts NB, Clark RV, Umpierrez G, Sgoutas D. Reversible impairment of gonadotropin secretion in critical illness: observations in postmenopausal women. Arch Intern Med 1989, 149:1637-1641. 10.1001/archinte.149.7.1637, 2500904.
20. Quint AR, Kaiser FE. Gonadotropin determinations and thyrotropin-releasing hormone and luteinizing hormone-releasing hormone testing in critically ill postmenopausal women with hypothyroxinemia. J Clin Endocrinol Metab 1985, 60:464-471. 10.1210/jcem-60-3-464, 3919044.
21. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab 1985, 60:444-450. 10.1210/jcem-60-3-444, 3919042.
22. Beishuizen A, Thijs LG, Vermes I. Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve?. Crit Care 2002, 6:434-438. 10.1186/cc1530, 130144, 12398784.
23. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124. 10.1056/NEJMoa071366, 18184957.
24. Dhatariya KK. Is there a role for dehydroepiandrosterone replacement in the intensive care population?. Intensive Care Med 2003, 29:1877-1880. 10.1007/s00134-003-1981-y, 12955180.
25. Mesotten D, Van den Berghe G. Changes within the growth hormone/insulin-like growth factor I/IGF binding protein axis during critical illness. Endocrinol Metab Clin North Am 2006, 35:793-805. ix-x, 10.1016/j.ecl.2006.09.010, 17127147.
26. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999, 341:785-792. 10.1056/NEJM199909093411102, 10477776.
27. Ziegler TR, Rombeau JL, Young LS, Fong Y, Marano M, Lowry SF, Wilmore DW. Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double-blind, randomized controlled study. J Clin Endocrinol Metab 1992, 74:865-873. 10.1210/jc.74.4.865, 1548352.
28. Schuetz P, Muller B, Nusbaumer C, Wieland M, Christ-Crain M. Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients. Eur J Endocrinol 2009, 160:157-163. 10.1530/EJE-08-0786, 19022915.
29. Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Veldhuis JD. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. J Clin Endocrinol Metab 2000, 85:183-192. 10.1210/jc.85.1.183, 10634385.
30. Jeschke MG, Barrow RE, Mlcak RP, Herndon DN. Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences. Ann Surg 2005, 241:759-768. 10.1097/01.sla.0000161028.43338.cd, 1357130, 15849511.
31. Valentin A, Jordan B, Lang T, Hiesmayr M, Metnitz PG. Gender-related differences in intensive care: a multiple-center cohort study of therapeutic interventions and outcome in critically ill patients. Crit Care Med 2003, 31:1901-1907. 10.1097/01.CCM.0000069347.78151.50, 12847381.
32. Combes A, Luyt CE, Trouillet JL, Nieszkowska A, Chastre J. Gender impact on the outcomes of critically ill patients with nosocomial infections. Crit Care Med 2009, 37:2506-2511. 10.1097/CCM.0b013e3181a569df, 19602974.
33. Gebregziabher M, Egede LE, Lynch CP, Echols C, Zhao Y. Effect of trajectories of glycemic control on mortality in type 2 diabetes: a semiparametric joint modeling approach. Am J Epidemiol 2010, 171:1090-1098. 10.1093/aje/kwq070, 20427326.
34. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297. 10.1056/NEJMoa0810625, 19318384.
35. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
36. Arem R, Wiener GJ, Kaplan SG, Kim HS, Reichlin S, Kaplan MM. Reduced tissue thyroid hormone levels in fatal illness. Metabolism 1993, 42:1102-1108. 10.1016/0026-0495(93)90266-Q, 8412761.
37. Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Gouwy S, Stockman W, Weekers F, Schetz M, Lauwers P, Bouillon R, Bowers CY. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues. Clin Endocrinol (Oxf) 1997, 47:599-612. 10.1046/j.1365-2265.1997.3371118.x, 9425400.
38. Gee AC, Sawai RS, Differding J, Muller P, Underwood S, Schreiber MA. The influence of sex hormones on coagulation and inflammation in the trauma patient. Shock 2008, 29:334-341.